{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:24:46Z","timestamp":1793741086202,"version":"4.6.1"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04539\/2020"],"award-info":[{"award-number":["UIDB\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04539\/2020"],"award-info":[{"award-number":["UIDP\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0058\/2020(JPND\/ 0001\/2022"],"award-info":[{"award-number":["LA\/P\/0058\/2020(JPND\/ 0001\/2022"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["DOI: 10.54499\/JPND\/0001\/2022; JPND\/0002\/2022"],"award-info":[{"award-number":["DOI: 10.54499\/JPND\/0001\/2022; JPND\/0002\/2022"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["DOI: 10.54499\/JPND\/0002\/2022"],"award-info":[{"award-number":["DOI: 10.54499\/JPND\/0002\/2022"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/120023\/2016; 2020.04850.BD"],"award-info":[{"award-number":["SFRH\/BD\/120023\/2016; 2020.04850.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.11293.BD"],"award-info":[{"award-number":["2022.11293.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018706","name":"HORIZON EUROPE Widening participation and spreading excellence","doi-asserted-by":"publisher","award":["GeneT project\u2014The Gene Therapy CoE at the Center of Portugal (Project ID: 101059981"],"award-info":[{"award-number":["GeneT project\u2014The Gene Therapy CoE at the Center of Portugal (Project ID: 101059981"]}],"id":[{"id":"10.13039\/100018706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018706","name":"HORIZON EUROPE Widening participation and spreading excellence","doi-asserted-by":"publisher","award":["DOI: 10.3030\/101059981); GCure \u2013 From Gene to Cure"],"award-info":[{"award-number":["DOI: 10.3030\/101059981); GCure \u2013 From Gene to Cure"]}],"id":[{"id":"10.13039\/100018706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018706","name":"HORIZON EUROPE Widening participation and spreading excellence","doi-asserted-by":"publisher","award":["ID: 101186929"],"award-info":[{"award-number":["ID: 101186929"]}],"id":[{"id":"10.13039\/100018706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018706","name":"HORIZON EUROPE Widening participation and spreading excellence","doi-asserted-by":"publisher","award":["DOI:10.3030\/101186929; GeneH - Excellence Hub for Advancing Innovation in Gene Therapy"],"award-info":[{"award-number":["DOI:10.3030\/101186929; GeneH - Excellence Hub for Advancing Innovation in Gene Therapy"]}],"id":[{"id":"10.13039\/100018706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018706","name":"HORIZON EUROPE Widening participation and spreading excellence","doi-asserted-by":"publisher","award":["ID: 101186939"],"award-info":[{"award-number":["ID: 101186939"]}],"id":[{"id":"10.13039\/100018706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018706","name":"HORIZON EUROPE Widening participation and spreading excellence","doi-asserted-by":"publisher","award":["DOI: 10.3030\/101186939"],"award-info":[{"award-number":["DOI: 10.3030\/101186939"]}],"id":[{"id":"10.13039\/100018706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The ketogenic diet (KD) is increasingly recognized as a promising therapeutic strategy for neurodegenerative disorders because of its multifaceted impacts on key pathophysiological mechanisms. This review explores the molecular pathways through which KD may protect against neurodegeneration, including the use of ketone bodies as alternative energy substrates, reduction of oxidative stress and inflammation, modulation of autophagy and protein aggregation, and impact on the gut microbiome. The potential benefits of KD are explored across neurodegenerative diseases such as Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease, amyotrophic lateral sclerosis, and multiple sclerosis, based on both preclinical and clinical evidence that supports its feasibility. However, challenges in long-term safety, patient adherence, and clinical practicality limit its widespread adoption. This review underscores the potential of KD for treating neurodegeneration on the basis of current scientific evidence while highlighting the need for further research to optimize its application and address existing gaps.<\/jats:p>","DOI":"10.1186\/s40035-026-00557-1","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T09:49:55Z","timestamp":1779702595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ketogenic diet as a therapeutic strategy for neurodegenerative diseases: from mechanisms to translational challenges"],"prefix":"10.1186","volume":"15","author":[{"given":"Ana Margarida","family":"Salgueiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Ferreira-Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo F. N.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela G.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda M.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Pereira","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Cavadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"557_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9:a028035.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"557_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-94-007-2869-1_12","volume":"942","author":"E Lezi","year":"2012","unstructured":"Lezi E, Swerdlow RH. Mitochondria in neurodegeneration. Adv Exp Med Biol. 2012;942:269\u201386.","journal-title":"Adv Exp Med Biol"},{"key":"557_CR3","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3233\/JAD-141074","volume":"43","author":"CA Castellano","year":"2014","unstructured":"Castellano CA, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, et al. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer\u2019s disease dementia. J Alzheimers Dis. 2014;43:1343\u201353.","journal-title":"J Alzheimers Dis"},{"key":"557_CR4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190086","volume":"218","author":"L Fontana","year":"2021","unstructured":"Fontana L, Ghezzi L, Cross AH, Piccio L. Effects of dietary restriction on neuroinflammation in neurodegenerative diseases. J Exp Med. 2021;218:e20190086.","journal-title":"J Exp Med"},{"key":"557_CR5","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/jnr.24075","volume":"95","author":"C Acosta","year":"2017","unstructured":"Acosta C, Anderson HD, Anderson CM. Astrocyte dysfunction in Alzheimer disease. J Neurosci Res. 2017;95:2430\u201347.","journal-title":"J Neurosci Res"},{"key":"557_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-05860-z","volume":"7","author":"J Di Lucente","year":"2024","unstructured":"Di Lucente J, Persico G, Zhou Z, Jin LW, Ramsey JJ, Rutkowsky JM, et al. Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer\u2019s mouse model and stimulates synaptic plasticity pathway enzymes. Commun Biol. 2024;7:195.","journal-title":"Commun Biol"},{"key":"557_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.mehy.2015.08.002","volume":"85","author":"MF McCarty","year":"2015","unstructured":"McCarty MF, DiNicolantonio JJ, O\u2019Keefe JH. Ketosis may promote brain macroautophagy by activating Sirt1 and hypoxia-inducible factor-1. Med Hypotheses. 2015;85:631\u20139.","journal-title":"Med Hypotheses"},{"key":"557_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0896-6273(02)00761-4","volume":"35","author":"PJ Muchowski","year":"2002","unstructured":"Muchowski PJ. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron. 2002;35:9\u201312.","journal-title":"Neuron"},{"key":"557_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10849","volume":"483","author":"J Gr\u00e4ff","year":"2012","unstructured":"Gr\u00e4ff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature. 2012;483:222\u20136.","journal-title":"Nature"},{"key":"557_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","volume":"181","author":"QY Ang","year":"2020","unstructured":"Ang QY, Alexander M, Newman JC, Tian Y, Cai J, Upadhyay V, et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell. 2020;181:1263-1275.e16.","journal-title":"Cell"},{"key":"557_CR11","first-page":"1","volume":"8","author":"D Ma","year":"2018","unstructured":"Ma D, Wang AC, Parikh I, Green SJ, Hoffman JD, Chlipala G, et al. Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice. Sci Rep. 2018;8:1\u201310.","journal-title":"Sci Rep"},{"key":"557_CR12","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1093\/brain\/awaf199","volume":"148","author":"RFN Ribeiro","year":"2025","unstructured":"Ribeiro RFN, Pereira D, Lopes SM, Reis T, Silva P, Lobo DD, et al. Circadian rhythms are disrupted in patients and preclinical models of Machado-Joseph disease. Brain. 2025;148:4127\u201342.","journal-title":"Brain"},{"key":"557_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00340-6","volume":"12","author":"Y Shen","year":"2023","unstructured":"Shen Y, Lv Q, Xie W, Gong S, Zhuang S, Liu J, et al. Circadian disruption and sleep disorders in neurodegeneration. Transl Neurodegen. 2023;12:8-.","journal-title":"Transl Neurodegen"},{"key":"557_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01421-12","volume":"33","author":"J Lee","year":"2013","unstructured":"Lee J, Moulik M, Fang Z, Saha P, Zou F, Xu Y, et al. Bmal1 and \u03b2-cell clock are required for adaptation to circadian disruption, and their loss of function leads to oxidative stress-induced \u03b2-cell failure in mice. Mol Cell Biol. 2013;33:2327.","journal-title":"Mol Cell Biol"},{"key":"557_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70317","volume":"123","author":"ES Musiek","year":"2013","unstructured":"Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y, et al. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J Clin Invest. 2013;123:5389.","journal-title":"J Clin Invest"},{"key":"557_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-2-28","volume":"2","author":"I Van Der Auwera","year":"2005","unstructured":"Van Der Auwera I, Wera S, Van Leuven F, Henderson ST. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer\u2019s disease. Nutr Metab (Lond). 2005;2:1\u20138.","journal-title":"Nutr Metab (Lond)"},{"key":"557_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00783-x","volume":"13","author":"MCL Phillips","year":"2021","unstructured":"Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13:51.","journal-title":"Alzheimers Res Ther"},{"key":"557_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27390","volume":"33","author":"MCL Phillips","year":"2018","unstructured":"Phillips MCL, Murtagh DKJ, Gilbertson LJ, Asztely FJS, Lynch CDP. Low\u2010fat versus ketogenic diet in Parkinson\u2019s disease: a pilot randomized controlled trial. Mov Disord. 2018;33:1306.","journal-title":"Mov Disord"},{"key":"557_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuroscience.2006.11.065","volume":"145","author":"M Maalouf","year":"2007","unstructured":"Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 2007;145:256\u201364.","journal-title":"Neuroscience"},{"key":"557_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ana.20899","volume":"60","author":"KJ Bough","year":"2006","unstructured":"Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol. 2006;60:223\u201335.","journal-title":"Ann Neurol"},{"key":"557_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome\u2013mediated inflammatory disease. Nat Med. 2015;21:263\u20139.","journal-title":"Nat Med"},{"key":"557_CR22","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.373715","volume":"18","author":"J Jiang","year":"2023","unstructured":"Jiang J, Pan H, Shen F, Tan Y, Chen S. Ketogenic diet alleviates cognitive dysfunction and neuroinflammation in APP\/PS1 mice via the Nrf2\/HO-1 and NF-\u03baB signaling pathways. Neural Regen Res. 2023;18:2767.","journal-title":"Neural Regen Res"},{"issue":"1","key":"557_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00831-w","volume":"7","author":"H Zhu","year":"2022","unstructured":"Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X, et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther. 2022;7(1):11.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"557_CR24","first-page":"540","volume":"56","author":"AL Rogovik","year":"2010","unstructured":"Rogovik AL, Goldman RD. Ketogenic diet for treatment of epilepsy. Can Fam Physician. 2010;56(6):540\u20132.","journal-title":"Can Fam Physician"},{"key":"557_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1528-1167.2007.01025.x","volume":"48","author":"HJ Seo","year":"2007","unstructured":"Seo HJ, Lee MY, Lee SJ, Kang CH, Kim DH. Efficacy and tolerability of the ketogenic diet according to lipid:nonlipid ratios\u2014comparison of 3:1 with 4:1 diet. Epilepsia. 2007;48:801\u20135.","journal-title":"Epilepsia"},{"key":"557_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/epi4.12225","volume":"3","author":"EH Kossoff","year":"2018","unstructured":"Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3:175.","journal-title":"Epilepsia Open"},{"key":"557_CR27","first-page":"307","volume":"2","author":"RM Wilder","year":"1921","unstructured":"Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clin Proc. 1921;2:307\u20138.","journal-title":"Mayo Clin Proc"},{"key":"557_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Du XL, Yamagishi SI, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787\u201390.","journal-title":"Nature"},{"key":"557_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05051-9","volume":"62","author":"S Ayoub","year":"2025","unstructured":"Ayoub S, Arabi M, Al-Najjar Y, Laswi I, Outeiro TF, Chaari A. Glycation in Alzheimer\u2019s disease and type 2 diabetes: the prospect of dual drug approaches for therapeutic interventions. Mol Neurobiol. 2025;62:14859.","journal-title":"Mol Neurobiol"},{"key":"557_CR30","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1038\/cddis.2013.180","volume":"4","author":"XH Li","year":"2013","unstructured":"Li XH, Du LL, Cheng XS, Jiang X, Zhang Y, Lv BL, et al. Glycation exacerbates the neuronal toxicity of \u03b2-amyloid. Cell Death Dis. 2013;4:e673\u2013e673.","journal-title":"Cell Death Dis"},{"key":"557_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122:1316.","journal-title":"J Clin Invest"},{"key":"557_CR32","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.4103\/1673-5374.274328","volume":"15","author":"B Polis","year":"2020","unstructured":"Polis B, Samson AO. Role of the metabolism of branched-chain amino acids in the development of Alzheimer\u2019s disease and other metabolic disorders. Neural Regen Res. 2020;15:1460\u201370.","journal-title":"Neural Regen Res"},{"key":"557_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.trci.2018.10.005","volume":"4","author":"M Tournissac","year":"2018","unstructured":"Tournissac M, Vandal M, Tremblay C, Bourassa P, Vancassel S, Emond V, et al. Dietary intake of branched-chain amino acids in a mouse model of Alzheimer\u2019s disease: effects on survival, behavior, and neuropathology. Alzheimers Dement Transl Res Clin Interv. 2018;4:677\u201387.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"557_CR34","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180127","volume":"38","author":"H Li","year":"2018","unstructured":"Li H, Ye D, Xie W, Hua F, Yang Y, Wu J, et al. Defect of branched-chain amino acid metabolism promotes the development of Alzheimer\u2019s disease by targeting the mTOR signaling. Biosci Rep. 2018;38:BSR20180127.","journal-title":"Biosci Rep"},{"key":"557_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s44324-024-00016-3","volume":"2","author":"A Schweickart","year":"2024","unstructured":"Schweickart A, Batra R, Neth BJ, Martino C, Shenhav L, Zhang AR, et al. Serum and CSF metabolomics analysis shows Mediterranean ketogenic diet mitigates risk factors of Alzheimer\u2019s disease. npj Metab Health Dis. 2024;2:15.","journal-title":"npj Metab Health Dis"},{"key":"557_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102497","volume":"11","author":"R Longo","year":"2019","unstructured":"Longo R, Peri C, Cricr\u00ec D, Coppi L, Caruso D, Mitro N, et al. Ketogenic diet: a new light shining on old but gold biochemistry. Nutrients. 2019;11:2497.","journal-title":"Nutrients"},{"key":"557_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2012","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2012;339:211.","journal-title":"Science"},{"key":"557_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-014-0230-3","volume":"12","author":"SP Fu","year":"2015","unstructured":"Fu SP, Wang JF, Xue WJ, Liu HM, Liu B, Zeng YL, et al. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson\u2019s disease models are mediated by GPR109A-dependent mechanisms. J Neuroinflammation. 2015;12:1\u201314.","journal-title":"J Neuroinflammation"},{"key":"557_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318797","volume":"112","author":"K Tieu","year":"2003","unstructured":"Tieu K, Perier C, Caspersen C, Teismann P, Wu D-C, Yan S-D, et al. D-\u03b2-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest. 2003;112:892.","journal-title":"J Clin Invest"},{"key":"557_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-7-29","volume":"7","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29.","journal-title":"BMC Neurosci"},{"key":"557_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.782657","volume":"8","author":"SM Gough","year":"2021","unstructured":"Gough SM, Casella A, Ortega KJ, Hackam AM. Neuroprotection by the ketogenic diet: evidence and controversies. Front Nutr. 2021;8:782657.","journal-title":"Front Nutr"},{"key":"557_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","volume":"25","author":"JC Newman","year":"2014","unstructured":"Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014;25:42\u201352.","journal-title":"Trends Endocrinol Metab"},{"key":"557_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091952","volume":"14","author":"D Pietrzak","year":"2022","unstructured":"Pietrzak D, Kasperek K, R\u0119kawek P, Pi\u0105tkowska-Chmiel I. The therapeutic role of ketogenic diet in neurological disorders. Nutrients. 2022;14:1952.","journal-title":"Nutrients"},{"key":"557_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/152165401753311780","volume":"51","author":"RL Veech","year":"2001","unstructured":"Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF. Ketone bodies, potential therapeutic uses. IUBMB Life. 2001;51:241\u20137.","journal-title":"IUBMB Life"},{"key":"557_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms4944","volume":"5","author":"M Rahman","year":"2014","unstructured":"Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, M\u00fcller-Fielitz H, et al. The \u03b2-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun. 2014;5:1\u201311.","journal-title":"Nat Commun"},{"key":"557_CR46","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2337\/db12-0548","volume":"62","author":"A Galmozzi","year":"2013","unstructured":"Galmozzi A, Mitro N, Ferrari A, Gers E, Gilardi F, Godio C, et al. Inhibition of class i histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes. 2013;62:732\u201342.","journal-title":"Diabetes"},{"key":"557_CR47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molcel.2016.03.036","volume":"62","author":"Z Xie","year":"2016","unstructured":"Xie Z, Zhang D, Chung D, Tang Z, Huang H, Dai L, et al. Metabolic regulation of gene expression by histone lysine \u03b2-hydroxybutyrylation. Mol Cell. 2016;62:194.","journal-title":"Mol Cell"},{"key":"557_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14368","volume":"24","author":"W Han","year":"2024","unstructured":"Han W, Zhang B, Zhao W, Zhao W, He J, Qiu X, et al. Ketogenic \u03b2-hydroxybutyrate regulates \u03b2-hydroxybutyrylation of TCA cycle-associated enzymes and attenuates disease-associated pathologies in Alzheimer\u2019s mice. Aging Cell. 2024;24:e14368.","journal-title":"Aging Cell"},{"key":"557_CR49","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/ana.20062","volume":"55","author":"PG Sullivan","year":"2004","unstructured":"Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol. 2004;55:576\u201380.","journal-title":"Ann Neurol"},{"key":"557_CR50","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.cmet.2014.10.005","volume":"20","author":"M Scheibye-Knudsen","year":"2014","unstructured":"Scheibye-Knudsen M, Mitchell SJ, Fang EF, Iyama T, Ward T, Wang J, et al. A high-fat diet and NAD+ activate Sirt1 to rescue premature aging in Cockayne syndrome. Cell Metab. 2014;20:840\u201355.","journal-title":"Cell Metab"},{"key":"557_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073875","volume":"8","author":"YS Hori","year":"2013","unstructured":"Hori YS, Kuno A, Hosoda R, Horio Y. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS ONE. 2013;8:e73875.","journal-title":"PLoS ONE"},{"key":"557_CR52","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1007\/s40520-022-02257-y","volume":"34","author":"RFN Ribeiro","year":"2022","unstructured":"Ribeiro RFN, Pereira D, de Almeida LP, Silva MMC, Cavadas C. SIRT1 activation and its circadian clock control: a promising approach against (frailty in) neurodegenerative disorders. Aging Clin Exp Res. 2022;34:2963\u201376.","journal-title":"Aging Clin Exp Res"},{"key":"557_CR53","first-page":"1","volume":"6","author":"L Zhou","year":"2016","unstructured":"Zhou L, Gao Q, Nie M, Gu JL, Hao W, Wang L, et al. Degeneration and energy shortage in the suprachiasmatic nucleus underlies the circadian rhythm disturbance in ApoE\u2212\/\u2212 mice: implications for Alzheimer\u2019s disease. Sci Rep. 2016;6:1\u201314.","journal-title":"Sci Rep"},{"key":"557_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109451","volume":"113","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Yin X, Wang M, Wang Y, Li F, Gao Y, et al. \u03b2-Hydroxybutyrate alleviates pyroptosis in MPP+\/MPTP-induced Parkinson\u2019s disease models via inhibiting STAT3\/NLRP3\/GSDMD pathway. Int Immunopharmacol. 2022;113:109451.","journal-title":"Int Immunopharmacol"},{"key":"557_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01948-5","volume":"17","author":"DC Shippy","year":"2020","unstructured":"Shippy DC, Wilhelm C, Viharkumar PA, Raife TJ, Ulland TK. \u03b2-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s disease pathology. J Neuroinflammation. 2020;17:280-.","journal-title":"J Neuroinflammation"},{"key":"557_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12031-010-9336-y","volume":"42","author":"X Yang","year":"2010","unstructured":"Yang X, Cheng B. Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. J Mol Neurosci. 2010;42:145\u201353.","journal-title":"J Mol Neurosci"},{"key":"557_CR57","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nature02583","volume":"429","author":"F Picard","year":"2004","unstructured":"Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, De Oliveira RM, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-\u03b3. Nature. 2004;429:771\u20136.","journal-title":"Nature"},{"key":"557_CR58","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.brainres.2005.12.061","volume":"1073\u20131074","author":"X Zhao","year":"2006","unstructured":"Zhao X, Ou Z, Grotta JC, Waxham N, Aronowski J. Peroxisome-proliferator-activated receptor-gamma (PPAR\u03b3) activation protects neurons from NMDA excitotoxicity. Brain Res. 2006;1073\u20131074:460\u20139.","journal-title":"Brain Res"},{"key":"557_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.neuroscience.2018.06.036","volume":"386","author":"E Hu","year":"2018","unstructured":"Hu E, Du H, Zhu X, Wang L, Shang S, Wu X, et al. Beta-hydroxybutyrate promotes the expression of BDNF in hippocampal neurons under adequate glucose supply. Neuroscience. 2018;386:315\u201325.","journal-title":"Neuroscience"},{"key":"557_CR60","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1046\/j.0022-3042.2001.00747.x","volume":"80","author":"J Lee","year":"2002","unstructured":"Lee J, Seroogy KB, Mattson MP. Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J Neurochem. 2002;80:539\u201347.","journal-title":"J Neurochem"},{"key":"557_CR61","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/jnr.22725","volume":"89","author":"W Guo","year":"2011","unstructured":"Guo W, Qian L, Zhang J, Zhang W, Morrison A, Hayes P, et al. Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J Neurosci Res. 2011;89:1723\u201336.","journal-title":"J Neurosci Res"},{"key":"557_CR62","doi-asserted-by":"publisher","first-page":"10892","DOI":"10.1074\/jbc.M800102200","volume":"283","author":"H Zhang","year":"2008","unstructured":"Zhang H, Bosch-Marce M, Shimoda LA, Yee ST, Jin HB, Wesley JB, et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem. 2008;283:10892\u2013903.","journal-title":"J Biol Chem"},{"key":"557_CR63","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","volume":"20","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3 C, Auwerx J. PGC-1\u03b1, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol. 2009;20:98\u2013105.","journal-title":"Curr Opin Lipidol"},{"key":"557_CR64","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1523\/JNEUROSCI.2369-17.2018","volume":"38","author":"SW Min","year":"2018","unstructured":"Min SW, Sohn PD, Li Y, Devidze N, Johnson JR, Krogan NJ, et al. SIRT1 deacetylates tau and reduces pathogenic tau spread in a mouse model of tauopathy. J Neurosci. 2018;38:3680.","journal-title":"J Neurosci"},{"key":"557_CR65","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.1067389","volume":"295","author":"PK Auluck","year":"2002","unstructured":"Auluck PK, Chan HYE, Trojanowski JQ, Lee VMY, Bonini NM. Chaperone suppression of \u03b1-synuclein toxicity in a Drosophila model for Parkinson\u2019s disease. Science. 2002;295:865\u20138.","journal-title":"Science"},{"key":"557_CR66","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","volume":"47","author":"R Nagpal","year":"2019","unstructured":"Nagpal R, Neth BJ, Wang S, Craft S, Yadav H. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019;47:529\u201342.","journal-title":"EBioMedicine"},{"key":"557_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150502","volume":"11","author":"SC Campbell","year":"2016","unstructured":"Campbell SC, Wisniewski PJ, Noji M, McGuinness LR, H\u00e4ggblom MM, Lightfoot SA, et al. The effect of diet and exercise on intestinal integrity and microbial diversity in mice. PLoS ONE. 2016;11:e0150502.","journal-title":"PLoS ONE"},{"key":"557_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.268","volume":"4","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Wang X, Zhang H, Yin J, Zhao P, Yin Q, et al. Ketogenic diet protects MPTP\u2010induced mouse model of Parkinson\u2019s disease via altering gut microbiota and metabolites. MedComm. 2023;4:e268.","journal-title":"MedComm"},{"key":"557_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01549-0","volume":"9","author":"W Zhang","year":"2023","unstructured":"Zhang W, Chen S, Huang X, Tong H, Niu H, Lu L. Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson\u2019s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome. Cell Death Discov. 2023;9:251.","journal-title":"Cell Death Discov"},{"key":"557_CR70","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomed. 2019;14:5541\u201354.","journal-title":"Int J Nanomed"},{"key":"557_CR71","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-2009-0972","volume":"16","author":"PI Moreira","year":"2009","unstructured":"Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer\u2019s disease. J Alzheimers Dis. 2009;16:741\u201361 (2).","journal-title":"J Alzheimers Dis"},{"key":"557_CR72","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","volume":"148","author":"P Raina","year":"2008","unstructured":"Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med. 2008;148:379\u201397.","journal-title":"Ann Intern Med"},{"key":"557_CR73","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2020;19:609\u201333.","journal-title":"Nat Rev Drug Discov"},{"key":"557_CR74","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3945\/ajcn.117.162263","volume":"106","author":"MK Taylor","year":"2017","unstructured":"Taylor MK, Sullivan DK, Swerdlow RH, Vidoni ED, Morris JK, Mahnken JD, et al. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults. Am J Clin Nutr. 2017;106:1463\u201370.","journal-title":"Am J Clin Nutr"},{"key":"557_CR75","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/cns.13779","volume":"28","author":"Y Xu","year":"2021","unstructured":"Xu Y, Jiang C, Wu J, Liu P, Deng X, Zhang Y, et al. Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer\u2019s disease. CNS Neurosci Ther. 2021;28:580.","journal-title":"CNS Neurosci Ther"},{"key":"557_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148404","volume":"1812","author":"Y Qin","year":"2023","unstructured":"Qin Y, Bai D, Tang M, Zhang M, Zhao L, Li J, et al. Ketogenic diet alleviates brain iron deposition and cognitive dysfunction via Nrf2-mediated ferroptosis pathway in APP\/PS1 mouse. Brain Res. 2023;1812:148404.","journal-title":"Brain Res"},{"key":"557_CR77","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neulet.2018.10.048","volume":"690","author":"M Ota","year":"2019","unstructured":"Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, et al. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer\u2019s disease. Neurosci Lett. 2019;690:232\u20136.","journal-title":"Neurosci Lett"},{"key":"557_CR78","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jalz.2018.12.017","volume":"15","author":"M Fortier","year":"2019","unstructured":"Fortier M, Castellano CA, Croteau E, Langlois F, Bocti C, St-Pierre V, et al. A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimers Dement. 2019;15:625\u201334.","journal-title":"Alzheimers Dement"},{"key":"557_CR79","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR. Parkinson\u2019s disease. Lancet. 2004;363:1783\u201393.","journal-title":"Lancet"},{"key":"557_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:1\u201321.","journal-title":"Nat Rev Dis Primers"},{"key":"557_CR81","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386:896\u2013912.","journal-title":"Lancet"},{"issue":"9","key":"557_CR82","volume":"16","author":"L Anwar","year":"2024","unstructured":"Anwar L, Ahmad E, Imtiaz M, Ahmad M, Aziz MF, ibad T. The impact of diet on Parkinson\u2019s disease: a systematic review. Cureus. 2024;16(9):e70337.","journal-title":"Cureus"},{"key":"557_CR83","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","volume":"97","author":"Y Kashiwaya","year":"2000","unstructured":"Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-\u03b2-hydroxybutyrate protects neurons in models of Alzheimer\u2019s and Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2000;97:5440\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"557_CR84","first-page":"63","volume":"15","author":"S Shaafi","year":"2016","unstructured":"Shaafi S, Najmi S, Aliasgharpour H, Mahmoudi J, Sadigh-Etemad S, Farhoudi M, et al. The efficacy of the ketogenic diet on motor functions in Parkinson\u2019s disease: A rat model. Iran J Neurol. 2016;15:63.","journal-title":"Iran J Neurol"},{"key":"557_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2019.07.006","volume":"1","author":"R Krikorian","year":"2019","unstructured":"Krikorian R, Shidler MD, Summer SS, Sullivan PG, Duker AP, Isaacson RS, et al. Nutritional ketosis for mild cognitive impairment in Parkinson\u2019s disease: a controlled pilot trial. Clin Parkinsonism Relat Disord. 2019;1:41.","journal-title":"Clin Parkinsonism Relat Disord"},{"key":"557_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03603-5","volume":"24","author":"AH Choi","year":"2024","unstructured":"Choi AH, Delgado M, Chen KY, Chung ST, Courville A, Turner SA, et al. A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson\u2019s disease. BMC Neurol. 2024;24:106.","journal-title":"BMC Neurol"},{"key":"557_CR87","doi-asserted-by":"publisher","DOI":"10.1080\/17582024.2024.2352394","volume":"14","author":"MM Tidman","year":"2024","unstructured":"Tidman MM, White DR, White TA. Impact of a keto diet on symptoms of Parkinson\u2019s disease, biomarkers, depression, anxiety and quality of life: a longitudinal study. Neurodegener Dis Manag. 2024;14:97.","journal-title":"Neurodegener Dis Manag"},{"key":"557_CR88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/B978-0-444-63233-3.00017-8","volume":"147","author":"R Ghosh","year":"2018","unstructured":"Ghosh R, Tabrizi SJ. Huntington disease. Handb Clin Neurol. 2018;147:255\u201378.","journal-title":"Handb Clin Neurol"},{"key":"557_CR89","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M804813200","volume":"284","author":"T Ratovitski","year":"2009","unstructured":"Ratovitski T, Gucek M, Jiang H, Chighladze E, Waldron E, D\u2019Ambola J, et al. Mutant Huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J Biol Chem. 2009;284:10855.","journal-title":"J Biol Chem"},{"key":"557_CR90","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/mds.24024","volume":"27","author":"A Rosenblatt","year":"2012","unstructured":"Rosenblatt A, Kumar BV, Mo A, Welsh CS, Margolis RL, Ross CA. Age, CAG repeat length, and clinical progression in Huntington\u2019s disease. Mov Disord. 2012;27:272\u20136.","journal-title":"Mov Disord"},{"key":"557_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Primers. 2015;1:1\u201321.","journal-title":"Nat Rev Dis Primers"},{"key":"557_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101385","volume":"70","author":"E Fields","year":"2021","unstructured":"Fields E, Vaughan E, Tripu D, Lim I, Shrout K, Conway J, et al. Gene targeting techniques for Huntington\u2019s disease. Ageing Res Rev. 2021;70:101385.","journal-title":"Ageing Res Rev"},{"key":"557_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2009.07.010","volume":"80","author":"RA Quintanilla","year":"2009","unstructured":"Quintanilla RA, Johnson GVW. Role of mitochondrial dysfunction in the pathogenesis of Huntington\u2019s disease. Brain Res Bull. 2009;80:242.","journal-title":"Brain Res Bull"},{"key":"557_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2013.116","volume":"67","author":"A Paoli","year":"2013","unstructured":"Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67:789 (6).","journal-title":"Eur J Clin Nutr"},{"key":"557_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2011.04.001","volume":"103","author":"DN Ruskin","year":"2011","unstructured":"Ruskin DN, Ross JL, Kawamura M, Ruiz TL, Geiger JD, Masino SA. A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6\/2 1J mouse model of Huntington\u2019s disease. Physiol Behav. 2011;103:501.","journal-title":"Physiol Behav"},{"key":"557_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024620","volume":"6","author":"S Lim","year":"2011","unstructured":"Lim S, Chesser AS, Grima JC, Rappold PM, Blum D, Przedborski S, et al. D-\u03b2-hydroxybutyrate is protective in mouse models of Huntington\u2019s disease. PLoS ONE. 2011;6:e24620.","journal-title":"PLoS ONE"},{"key":"557_CR97","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","volume":"48","author":"RH Myers","year":"1991","unstructured":"Myers RH, Sax DS, Kiely DK, Pettengill FK, Koroshetz WJ, Mastromauro C, et al. Factors associated with slow progression in Huntington\u2019s disease. Arch Neurol. 1991;48:800\u20134.","journal-title":"Arch Neurol"},{"key":"557_CR98","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-150181","volume":"5","author":"JY Chen","year":"2016","unstructured":"Chen JY, Tran C, Hwang L, Deng G, Jung ME, Faull KF, et al. Partial amelioration of peripheral and central symptoms of Huntington\u2019s disease via modulation of lipid metabolism. J Huntington\u2019s Dis. 2016;5:65.","journal-title":"J Huntington's Dis"},{"key":"557_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.931636","volume":"16","author":"MCL Phillips","year":"2022","unstructured":"Phillips MCL, McManus EJ, Brinkhuis M, Romero-Ferrando B. Time-restricted ketogenic diet in Huntington\u2019s disease: a case study. Front Behav Neurosci. 2022;16:931636.","journal-title":"Front Behav Neurosci"},{"key":"557_CR100","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918\u201329.","journal-title":"Eur J Neurol"},{"key":"557_CR101","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/364362c0","volume":"364","author":"D Rosen","year":"1993","unstructured":"Rosen D. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362\u2013362.","journal-title":"Nature"},{"key":"557_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049191","volume":"7","author":"W Zhao","year":"2012","unstructured":"Zhao W, Varghese M, Vempati P, Dzhun A, Cheng A, Wang J, et al. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS ONE. 2012;7:e49191.","journal-title":"PLoS ONE"},{"key":"557_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1329541","volume":"14","author":"MCL Phillips","year":"2024","unstructured":"Phillips MCL, Johnston SE, Simpson P, Chang DK, Mather D, Dick RJ. Time-restricted ketogenic diet in amyotrophic lateral sclerosis: a case study. Front Neurol. 2024;14:1329541.","journal-title":"Front Neurol"},{"key":"557_CR104","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","volume":"20","author":"H Ford","year":"2020","unstructured":"Ford H. Clinical presentation and diagnosis of multiple sclerosis. Clin Med. 2020;20:380\u20133.","journal-title":"Clin Med"},{"key":"557_CR105","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of Multiple Sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26:1816\u201321.","journal-title":"Mult Scler"},{"key":"557_CR106","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1179\/016164106X98099","volume":"28","author":"GP Owens","year":"2006","unstructured":"Owens GP, Bennett JL, Gilden DH, Burgoon MP. The B cell response in multiple sclerosis. Neurol Res. 2006;28:236\u201344.","journal-title":"Neurol Res"},{"key":"557_CR107","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47:707\u201317.","journal-title":"Ann Neurol"},{"key":"557_CR108","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM, Rudick R, M\u00f6rk S, B\u00f6 L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278\u201385.","journal-title":"N Engl J Med"},{"key":"557_CR109","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awn105","volume":"131","author":"D Mahad","year":"2008","unstructured":"Mahad D, Ziabreva I, Lassmann H, Turnbull D. Mitochondrial defects in acute multiple sclerosis lesions. Brain. 2008;131:1722.","journal-title":"Brain"},{"key":"557_CR110","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.22109","volume":"69","author":"GR Campbell","year":"2011","unstructured":"Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol. 2011;69:481.","journal-title":"Ann Neurol"},{"key":"557_CR111","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/brain\/awp046","volume":"132","author":"DJ Mahad","year":"2009","unstructured":"Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, et al. Mitochondrial changes within axons in multiple sclerosis. Brain. 2009;132:1161.","journal-title":"Brain"},{"key":"557_CR112","doi-asserted-by":"crossref","unstructured":"Randomised double-blind placebo-controlled study of interferon \u03b2-1a in relapsing\/remitting multiple sclerosis. Lancet. 1998;352(9139):1498\u2013504.","DOI":"10.1016\/S0140-6736(98)03334-0"},{"key":"557_CR113","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O\u2019Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006;354:899\u2013910.","journal-title":"N Engl J Med"},{"key":"557_CR114","first-page":"30","volume":"18","author":"F Riederer","year":"2017","unstructured":"Riederer F. Ocrelizumab versus placebo in primary progressive multiple sclerosis. Journal fur Neurologie, Neurochirurgie und Psychiatrie. 2017;18:30\u20131.","journal-title":"Journal fur Neurologie, Neurochirurgie und Psychiatrie"},{"key":"557_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035476","volume":"7","author":"DY Kim","year":"2012","unstructured":"Kim DY, Hao J, Liu R, Turner G, Shi FD, Rho JM. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS ONE. 2012;7:e35476.","journal-title":"PLoS ONE"},{"key":"557_CR116","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1039\/D3FO00122A","volume":"14","author":"W Sun","year":"2023","unstructured":"Sun W, Wang Q, Zhang R, Zhang N. Ketogenic diet attenuates neuroinflammation and induces conversion of M1 microglia to M2 in an EAE model of multiple sclerosis by regulating the NF-\u03baB\/NLRP3 pathway and inhibiting HDAC3 and P2X7R activation. Food Funct. 2023;14:7247\u201369.","journal-title":"Food Funct"},{"key":"557_CR117","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1039\/C9FO02944C","volume":"11","author":"N Zhang","year":"2020","unstructured":"Zhang N, Liu C, Zhang R, Jin L, Yin X, Zheng X, et al. Amelioration of clinical course and demyelination in the cuprizone mouse model in relation to ketogenic diet. Food Funct. 2020;11:5647\u201363.","journal-title":"Food Funct"},{"key":"557_CR118","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2022-329074","volume":"93","author":"JN Brenton","year":"2022","unstructured":"Brenton JN, Lehner-Gulotta D, Woolbright E, Banwell B, Bergqvist AGC, Chen S, et al. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93:637.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"557_CR119","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40795-025-01156-5","volume":"11","author":"LS Bahr","year":"2025","unstructured":"Bahr LS, Bellmann-Strobl J, Koppold DA, Rust R, Schmitz-H\u00fcbsch T, Olszewska M, et al. Fasting, ketogenic, and anti-inflammatory diets in multiple sclerosis: a randomized controlled trial with 18-month follow-up. BMC Nutr. 2025;11:167.","journal-title":"BMC Nutr"},{"key":"557_CR120","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ebiom.2018.08.057","volume":"36","author":"M Bock","year":"2018","unstructured":"Bock M, Karber M, Kuhn H. Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis. EBioMedicine. 2018;36:293.","journal-title":"EBioMedicine"},{"key":"557_CR121","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001102","volume":"9","author":"M Bock","year":"2021","unstructured":"Bock M, Steffen F, Zipp F, Bittner S. Impact of dietary intervention on serum neurofilament light chain in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021;9:e1102.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"557_CR122","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1001\/archinte.166.3.285","volume":"166","author":"AJ Nordmann","year":"2006","unstructured":"Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS, Brehm BJ, et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:285\u201393.","journal-title":"Arch Intern Med"},{"key":"557_CR123","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/nmt-2021-0033","volume":"12","author":"MM Tidman","year":"2022","unstructured":"Tidman MM, White D, White T. Effects of an low carbohydrate\/healthy fat\/ketogenic diet on biomarkers of health and symptoms, anxiety and depression in Parkinson\u2019s disease: a pilot study. Neurodegener Dis Manag. 2022;12:57\u201366.","journal-title":"Neurodegener Dis Manag"},{"key":"557_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-023-02874-y","volume":"21","author":"C Patikorn","year":"2023","unstructured":"Patikorn C, Saidoung P, Pham T, Phisalprapa P, Lee YY, Varady KA, et al. Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials. BMC Med. 2023;21:1\u201312.","journal-title":"BMC Med"},{"key":"557_CR125","volume":"7","author":"ECS Bostock","year":"2020","unstructured":"Bostock ECS, Kirkby KC, Taylor BV, Hawrelak JA. Consumer reports of \u201cketo flu\u201d associated with the ketogenic diet. Front Nutr. 2020;7:511082.","journal-title":"Front Nutr"},{"key":"557_CR126","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pediatrneurol.2017.01.007","volume":"68","author":"A Lin","year":"2017","unstructured":"Lin A, Turner Z, Doerrer SC, Stanfield A, Kossoff EH. Complications during ketogenic diet initiation: prevalence, treatment, and influence on seizure outcomes. Pediatr Neurol. 2017;68:35\u20139.","journal-title":"Pediatr Neurol"},{"key":"557_CR127","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejpn.2018.11.007","volume":"23","author":"O Guzel","year":"2019","unstructured":"Guzel O, Uysal U, Arslan N. Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: a single center experience from Turkey. Eur J Paediatr Neurol. 2019;23:143\u201351.","journal-title":"Eur J Paediatr Neurol"},{"issue":"702802","key":"557_CR128","first-page":"2802","volume":"8","author":"L Crosby","year":"2021","unstructured":"Crosby L, Davis B, Joshi S, Jardine M, Paul J, Neola M, et al. Ketogenic diets and chronic disease: weighing the benefits against the risks. Front Nutr. 2021;8(702802):2802.","journal-title":"Front Nutr"},{"key":"557_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092616","volume":"12","author":"IM Zarnowska","year":"2020","unstructured":"Zarnowska IM. Therapeutic use of the ketogenic diet in refractory epilepsy: what we know and what still needs to be learned. Nutrients. 2020;12:2616.","journal-title":"Nutrients"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00557-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:02:19Z","timestamp":1779706939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40035-026-00557-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1186\/s40035-026-00557-1","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors claim that there are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}